GS-441524 Parent Nucleoside to Remdesivir Can Effectively Inhibits Sars-Cov-2 Omicron Infections in Human Lung Organoids

被引：0
|
作者：
Liang, J. [1 ]
Li, Y. [2 ]
Khateeb, J. [3 ]
Khang, J. [4 ]
Slutsky, A. [5 ]
Mubareka, S. [6 ]
Zhang, H. [7 ]
机构：
[1] Univ Toronto, Physiol, Toronto, ON, Canada
[2] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Rambam Hlth Care Campus, Internal Med, Haifa, Israel
[4] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Anesthesia, Toronto, ON, Canada
[5] St Michaels Hosp, Interdepartmental Div Crit Care Medici, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Lab Med & Pathobiol, Toronto, ON, Canada
[7] St Michaels Hosp, Anesthesia & Pain Med, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3983
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models
    Li, Yingjun
    Cao, Liu
    Li, Ge
    Cong, Feng
    Li, Yunfeng
    Sun, Jing
    Luo, Yinzhu
    Chen, Guijiang
    Li, Guanguan
    Wang, Ping
    Xing, Fan
    Ji, Yanxi
    Zhao, Jincun
    Zhang, Yu
    Guo, Deyin
    Zhang, Xumu
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2785 - 2793
  • [2] Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
    Cox, Robert M.
    Wolf, Josef D.
    Lieber, Carolin M.
    Sourimant, Julien
    Lin, Michelle J.
    Babusis, Darius
    DuPont, Venice
    Chan, Julie
    Barrett, Kim T.
    Lye, Diane
    Kalla, Rao
    Chun, Kwon
    Mackman, Richard L.
    Ye, Chengjin
    Cihlar, Tomas
    Martinez-Sobrido, Luis
    Greninger, Alexander L.
    Bilello, John P.
    Plemper, Richard K.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [3] Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
    Robert M. Cox
    Josef D. Wolf
    Carolin M. Lieber
    Julien Sourimant
    Michelle J. Lin
    Darius Babusis
    Venice DuPont
    Julie Chan
    Kim T. Barrett
    Diane Lye
    Rao Kalla
    Kwon Chun
    Richard L. Mackman
    Chengjin Ye
    Tomas Cihlar
    Luis Martinez-Sobrido
    Alexander L. Greninger
    John P. Bilello
    Richard K. Plemper
    Nature Communications, 12
  • [4] Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants
    Pitts, Jared
    Li, Jiani
    Perry, Jason K.
    Du Pont, Venice
    Riola, Nicholas
    Rodriguez, Lauren
    Lu, Xianghan
    Kurhade, Chaitanya
    Xie, Xuping
    Camus, Gregory
    Manhas, Savrina
    Martin, Ross
    Shi, Pei-Yong
    Cihlar, Tomas
    Porter, Danielle P.
    Mo, Hongmei
    Maiorova, Evguenia
    Bilello, John P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [5] The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
    JiaYi Zhu
    Yuchong Li
    Jady Liang
    Samira Mubareka
    Arthur S. Slutsky
    Haibo Zhang
    Intensive Care Research, 2022, 2 (3-4): : 49 - 60
  • [6] Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
    Ni, Xiaomin
    Schroeder, Martin
    Olieric, Vincent
    Sharpe, May E.
    Hernandez-Olmos, Victor
    Proschak, Ewgenij
    Merk, Daniel
    Knapp, Stefan
    Chaikuad, Apirat
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (04): : 603 - 609
  • [7] Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2
    Wei, Daibao
    Hu, Tianwen
    Zhang, Yumin
    Zheng, Wei
    Xue, Haitao
    Shen, Jingshan
    Xie, Yuanchao
    Aisa, Haji A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 46
  • [8] Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
    Xie, Jiashu
    Wang, Zhengqiang
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (06) : 1607 - 1616
  • [9] Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
    Jiashu Xie
    Zhengqiang Wang
    Acta Pharmaceutica Sinica B, 2021, 11 (06) : 1607 - 1616
  • [10] Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
    Chiba, Shiho
    Kiso, Maki
    Nakajima, Noriko
    Iida, Shun
    Maemura, Tadashi
    Kuroda, Makoto
    Sato, Yuko
    Ito, Mutsumi
    Okuda, Moe
    Yamada, Shinya
    Iwatsuki-Horimoto, Kiyoko
    Watanabe, Tokiko
    Imai, Masaki
    Armbrust, Tammy
    Baric, Ralph S.
    Halfmann, Peter J.
    Suzuki, Tadaki
    Kawaoka, Yoshihiro
    MBIO, 2022, 13 (01):
12345